Market Cap (In CNY)
3.99 Billion
Revenue (In CNY)
2.29 Billion
Net Income (In CNY)
-388.96 Million
Avg. Volume
32.64 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.0-16.49
- PE
- -8.66
- EPS
- -0.7
- Beta Value
- 0.518
- ISIN
- CNE100000Y92
- CUSIP
- -
- CIK
- -
- Shares
- 658718498.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Yonghui Wang
- Employee Count
- -
- Website
- https://www.xphcn.com
- Ipo Date
- 2010-12-15
- Details
- Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China's traditional Chinese medicine industry. The company was founded in 1997 and is based in Guangzhou, China.
More Stocks
-
SAABYSaab AB (publ)
SAABY
-
603076
-
GWO-PIGreat-West Lifeco Inc.
GWO-PI
-
MTN
-
RHIM
-
EDTXFSpectral Medical Inc.
EDTXF
-
SPOKSpok Holdings, Inc.
SPOK
-
FULT